NCT03584594View on ClinicalTrials.gov

Presepsin in the Diagnosis of Sepsis in Critically Ill Patients

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

March 30, 2022

Conditions
SepsisInfection
Interventions
DIAGNOSTIC_TEST

Presepsin measurement

Presepsin measurements are performed with PathFast immunoassay analytical system on the ICU, bedside method. (Mitsubishi Chemical, Japan).

Trial Locations (2)

702 00

Public Health Institute Ostrava, Ostrava

780 52

University Hospital Ostrava, Ostrava

All Listed Sponsors
collaborator

Public Health Institute Ostrava

UNKNOWN

lead

University Hospital Ostrava

OTHER

NCT03584594 - Presepsin in the Diagnosis of Sepsis in Critically Ill Patients | Biotech Hunter | Biotech Hunter